Hayward, CA, United States of America

Susan Catalano



Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Susan Catalano in Oncology Research

Introduction

Susan Catalano is a prominent inventor based in Hayward, CA, with a remarkable portfolio of 7 patents. Her groundbreaking work primarily focuses on developing innovative solutions in the field of oncology. Catalano's contributions have made significant strides in cancer research, showcasing her dedication to improving patient outcomes through technology and innovative methodologies.

Latest Patents

Among her latest patents is a system and method for high-content oncology assay. This invention presents an apparatus, system, method, as well as a computer program designed for analyzing cellular samples. One notable embodiment of this apparatus provides a multiparameter assay that delivers critical information regarding cell proliferation, cell cycling, and cell death. This multiparameter assay is particularly beneficial for assessing and screening candidate compounds intended for anti-cancer utility.

Another recent invention by Catalano involves 2,4-pyrimidinediamine compounds and their uses as anti-proliferative agents. This patent discloses compounds with antiproliferative activity, formulations that include these compounds, and methods for utilizing them to inhibit cellular proliferation and treat proliferative conditions, such as tumorigenic cancers.

Career Highlights

Susan Catalano is currently affiliated with Rigel Pharmaceuticals, Incorporated, where she plays a crucial role in advancing cancer treatment technologies. Her extensive knowledge and innovative thinking have positioned her as a leader in her field, making notable contributions that enhance pharmaceutical research and development.

Collaborations

Throughout her career, Catalano has collaborated with talented professionals in the industry, including John McLaughlin and Ankush Argade. These collaborations have not only bolstered her research efforts but also fostered an environment of innovation and creativity within the field of oncology.

Conclusion

In summary, Susan Catalano's inventive work is making a significant impact on cancer research and treatment. Her patents reflect her commitment to developing effective solutions for cancer-related diseases. As a dedicated inventor and collaborator, Catalano continues to push the boundaries of innovation in healthcare, ultimately striving to improve the lives of patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…